A New Class of Cancer Drugs May Be Less Toxic
Experimental treatments use an antibody to guide a toxic chemotherapy agent to cancer cells, limiting the toxin’s attack to the cancer and minimizing side effects.
Experimental treatments use an antibody to guide a toxic chemotherapy agent to cancer cells, limiting the toxin’s attack to the cancer and minimizing side effects.
ATLANTA — For the first time, the government is proposing that all baby boomers get tested for hepatitis C.
HORSHOLM, Denmark, May 15, 2012 /PRNewswire/ –Highlights: Enrolment has been completed in the pivotal LCP-Tacro 3002 Phase III study in de novo kidney transplant patients. The LCP-Tacro 3002 study is …
EDMONTON, Alberta — Isotechnika Pharma Inc. today announced financial results for the three months ended March 31, 2012.
A former federal prosecutor has marijuana activists mobilizing against his campaign.
Ein hoher Koordinationsaufwand erwartet Kunststoffverarbeiter, die erfolgreich globalisieren…
MONTREAL– – Bio-Solutions Corp is pleased to announce a new era. The company will be changing its core business away from GREENEX™ and NutraAnimal™, in order to focus entirely on Type2 Defense™. Type2 …
SAN DIEGO — Vical Incorporated today reported financial results for the quarter ended March 31, 2012. Revenues increased to $11.5 million for the first quarter of 2012 compared with $0.6 million for the …
My CRO client is seeking a talented Director/Senior Director Business Development to sell their core services in Germany, Switzerland and Austria. Reporting into the European Head of Business Development, this is a unique opportunity to work with a glo…
James Kaskie has a lot on his plate these days. As CEO of Kaleida Health and Great Lakes Health –the new parent of Kaleida and Erie County Medical Center–Kaskie oversees the region’s largest and most influential hospital system and health care pr…